520880 港股通创新药ETF华宝
已收盘 09-04 15:00:00
资讯
新帖
简况
创新药企密集进入临床数据验证期,石药集团涨超4%!华宝基金港股通创新药ETF(520880)再收半年线!
新浪基金 · 09-03 10:52
创新药企密集进入临床数据验证期,石药集团涨超4%!华宝基金港股通创新药ETF(520880)再收半年线!
【ETF动向】8月27日港股通创新药ETF华宝基金涨1.27%,份额减少1.5亿份
证券之星 · 08-28
【ETF动向】8月27日港股通创新药ETF华宝基金涨1.27%,份额减少1.5亿份
创新药反复活跃,后市怎么走?华宝基金港股通创新药ETF(520880)基金经理火线拆解行情逻辑!
新浪基金 · 08-27
创新药反复活跃,后市怎么走?华宝基金港股通创新药ETF(520880)基金经理火线拆解行情逻辑!
【ETF动向】8月25日港股通创新药ETF华宝基金涨1.1%,份额减少7000万份
证券之星 · 08-26
【ETF动向】8月25日港股通创新药ETF华宝基金涨1.1%,份额减少7000万份
创新药火速修复,520880成反弹急先锋!场内唯一药ETF8天7涨!映恩生物、艾力斯、荣昌生物等多股释放利好
新浪基金 · 07-20
创新药火速修复,520880成反弹急先锋!场内唯一药ETF8天7涨!映恩生物、艾力斯、荣昌生物等多股释放利好
港股通创新药突遭重挫,520880放量溢价!A股制药板块韧性凸显,场内唯一药ETF周线逆市收红
新浪基金 · 07-19
港股通创新药突遭重挫,520880放量溢价!A股制药板块韧性凸显,场内唯一药ETF周线逆市收红
创新药遭“错杀”?AH十余股狂泻逾10%!港股通创新药ETF(520880)、场内唯一药ETF同创历史最大单日跌幅
新浪基金 · 07-17
创新药遭“错杀”?AH十余股狂泻逾10%!港股通创新药ETF(520880)、场内唯一药ETF同创历史最大单日跌幅
【ETF动向】7月15日港股通创新药ETF华宝基金涨3.81%,份额减少1.1亿份
证券之星 · 07-16
【ETF动向】7月15日港股通创新药ETF华宝基金涨3.81%,份额减少1.1亿份
创新药再度活跃!场内唯一药ETF(562050)逆市涨超1%四连升!港股通创新药ETF华宝(520880)盘中翻红!
新浪基金 · 07-14
创新药再度活跃!场内唯一药ETF(562050)逆市涨超1%四连升!港股通创新药ETF华宝(520880)盘中翻红!
【ETF动向】7月10日港股通创新药ETF华宝基金涨3.46%,份额减少1.1亿份
证券之星 · 07-11
【ETF动向】7月10日港股通创新药ETF华宝基金涨3.46%,份额减少1.1亿份
19亿美元!国产创新药叒爆BD大单!港股通创新药应声反弹,520880摸高2.54%
新浪基金 · 07-09
19亿美元!国产创新药叒爆BD大单!港股通创新药应声反弹,520880摸高2.54%
【ETF动向】7月6日港股通创新药ETF华宝基金涨2.73%,份额减少1.1亿份
证券之星 · 07-07
【ETF动向】7月6日港股通创新药ETF华宝基金涨2.73%,份额减少1.1亿份
爆量突破!超级赛道回归?港股通创新药ETF华宝(520880)冲高6.36%,场内唯一药ETF逆市四连阳!
新浪基金 · 07-06
爆量突破!超级赛道回归?港股通创新药ETF华宝(520880)冲高6.36%,场内唯一药ETF逆市四连阳!
【ETF动向】7月2日港股通创新药ETF华宝基金涨3.7%,份额减少1.1亿份
证券之星 · 07-03
【ETF动向】7月2日港股通创新药ETF华宝基金涨3.7%,份额减少1.1亿份
顿悟了!玻璃不仅能造芯片,还能装药...
新浪基金 · 06-30
顿悟了!玻璃不仅能造芯片,还能装药...
【ETF动向】6月29日港股通创新药ETF华宝基金涨7.94%,份额减少1.1亿份
证券之星 · 06-30
【ETF动向】6月29日港股通创新药ETF华宝基金涨7.94%,份额减少1.1亿份
创新药再陷调整!场内唯一药ETF止步四连涨,港股通创新药大面积飘绿,520880跌逾2.5%
新浪基金 · 06-25
创新药再陷调整!场内唯一药ETF止步四连涨,港股通创新药大面积飘绿,520880跌逾2.5%
【ETF动向】6月24日港股通创新药ETF华宝基金涨2.36%,份额减少1亿份
证券之星 · 06-25
【ETF动向】6月24日港股通创新药ETF华宝基金涨2.36%,份额减少1亿份
CXO成反弹急先锋?高CXO含量港股通医疗ETF华宝(159137)盘中劲涨5.44%!创新药同步回血,520880上探4%
新浪基金 · 06-24
CXO成反弹急先锋?高CXO含量港股通医疗ETF华宝(159137)盘中劲涨5.44%!创新药同步回血,520880上探4%
【ETF动向】6月12日港股通创新药ETF华宝基金涨3.66%,份额减少9000万份
证券之星 · 06-13
【ETF动向】6月12日港股通创新药ETF华宝基金涨3.66%,份额减少9000万份
加载更多
公司概况
公司名称:
--
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"520880","market":"SH","secType":"STK","nameCN":"港股通创新药ETF华宝","latestPrice":0.468,"timestamp":1788505200000,"preClose":0.464,"halted":0,"volume":902068500,"delay":0,"changeRate":0.0086,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":0.004,"latestTime":"09-04 15:00:00","open":0.468,"high":0.474,"low":0.466,"amount":422000000,"amplitude":0.0172,"askPrice":0.469,"askSize":105416,"bidPrice":0.468,"bidSize":39787,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788744600000},"marketStatusCode":5,"adr":0,"adjPreClose":0.464,"symbolType":"fund","openAndCloseTimeList":[[1788485400000,1788492600000],[1788498000000,1788505200000]],"highLimit":0.51,"lowLimit":0.418,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"committee":-0.369324,"marketValue":0,"turnoverRate":0,"status":0,"floatMarketCap":0},"requestUrl":"/m/hq/s/520880","defaultTab":"news","newsList":[{"id":"2664231028","title":"创新药企密集进入临床数据验证期,石药集团涨超4%!华宝基金港股通创新药ETF(520880)再收半年线!","url":"https://stock-news.laohu8.com/highlight/detail?id=2664231028","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664231028?lang=zh_cn&edition=full","pubTime":"2026-09-03 10:52","pubTimestamp":1788403920,"startTime":"0","endTime":"0","summary":"9月3日,港股创新药链继续活跃,创新药龙头公司领涨,石药集团、中国生物制药双双涨超4%。纯正创新药指数——恒生港股通创新药精选指数一度冲高逾2%,跟踪该指数的港股通创新药ETF华宝盘中再收半年线。中金公司提示,创新药较多公司进入临床数据验证阶段,值得自下而上关注。据统计,港股通创新药ETF华宝覆盖的48家创新药研发公司中,31家上半年实现盈利,归母净利同比正增长的有33家,占比近7成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-03/doc-iniqpkry1034045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","KURE","IE0008369823.USD","LU1152091168.USD","LU1226288253.USD","LU0501845795.SGD","520880","LU1226288170.HKD","LU0072913022.USD","BK1191","SG9999004220.SGD","LU1951186391.HKD","BK1574","IE00BZ08YR35.GBP","LU0880133367.SGD","159316","IE0008368742.USD","LU2039709279.SGD","MEDX","LNGR","LU1226287792.SGD","IE00B5MMRT66.SGD","LU1152091754.HKD","LU1993786604.SGD","LU1960683339.HKD","LU0314109678.HKD","LU1226287529.USD","BK1515","FLHK","06978","LU1226287875.USD","LU0067412154.USD","01093","IE00B031HY20.USD","IE00BZ08YT58.USD","BK1161","LU1813983027.USD","LU0326950275.SGD","LU1328277881.USD","IE00B543WZ88.USD","IBBQ","LU1807302812.USD","BK1521","HK0000165453.HKD","LU0315179316.USD","IE00BZ08YS42.EUR","LU0140636845.USD","LU1008478684.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662039137","title":"【ETF动向】8月27日港股通创新药ETF华宝基金涨1.27%,份额减少1.5亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2662039137","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662039137?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:32","pubTimestamp":1787869958,"startTime":"0","endTime":"0","summary":"证券之星消息,8月27日,港股通创新药ETF华宝基金(520880)涨1.27%,成交额3.93亿元。当日份额减少了1.5亿份,最新份额为44.36亿份,近20个交易日份额减少6.62亿份。当日资金净流出3785.43万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为21.5亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-4.1%,近一个月超额回报为-0.06%,管理人为华宝基金公司,基金经理为丰晨成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800011987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662992722","title":"创新药反复活跃,后市怎么走?华宝基金港股通创新药ETF(520880)基金经理火线拆解行情逻辑!","url":"https://stock-news.laohu8.com/highlight/detail?id=2662992722","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662992722?lang=zh_cn&edition=full","pubTime":"2026-08-27 11:20","pubTimestamp":1787800800,"startTime":"0","endTime":"0","summary":"100%创新药研发标的——港股通创新药ETF华宝关注度持续升温。图:港股通创新药ETF华宝近6个月日K走势如何看待近期创新药行情?港股通创新药ETF华宝基金经理丰晨成最新解读来了,三个维度拆解行情逻辑。全链布局创新药,关注两大T+0交易利器:港股通创新药ETF华宝:被动跟踪恒生港股通创新药精选指数,100%布局创新药研发类公司,7成仓位押注研发龙头。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-27/doc-iniptnux9036538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","520880","BK1161","159316","06978","MEDX","IBBQ","LNGR","159992","FLHK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662502357","title":"【ETF动向】8月25日港股通创新药ETF华宝基金涨1.1%,份额减少7000万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2662502357","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662502357?lang=zh_cn&edition=full","pubTime":"2026-08-26 06:32","pubTimestamp":1787697165,"startTime":"0","endTime":"0","summary":"证券之星消息,8月25日,港股通创新药ETF华宝基金(520880)涨1.1%,成交额4亿元。当日份额减少了7000万份,最新份额为46.96亿份,近20个交易日份额减少4.18亿份。当日资金净流出223.9万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为21.96亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-3.92%,近一个月超额回报为-0.07%,管理人为华宝基金公司,基金经理为丰晨成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600010742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652290964","title":"创新药火速修复,520880成反弹急先锋!场内唯一药ETF8天7涨!映恩生物、艾力斯、荣昌生物等多股释放利好","url":"https://stock-news.laohu8.com/highlight/detail?id=2652290964","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652290964?lang=zh_cn&edition=full","pubTime":"2026-07-20 19:19","pubTimestamp":1784546340,"startTime":"0","endTime":"0","summary":"周一,AH医药资产经历上周“黑色星期五”后率先迎来修复。港股通医药弹性十足,港股通创新药ETF华宝、港股通医疗ETF华宝大涨4.17%、3.27%。A股医药逆市活跃,药ETF华宝、医疗ETF华宝携手反弹2.5%。 港股通创新药全天强势,100%创新药研发标的——520880盘中一度上探4.63%,放量成交8.1亿元。 A股制药板块同步反弹,场内唯一跟踪制药指数的药ETF华宝低开后直线拉升翻红,盘中冲高3%,收涨2.58%走出“8天7涨”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-07-20/doc-iniinfqe4980267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1064130708.USD","MEDX","688578","LU2328871848.SGD","688331","BK1574","LU1064131003.USD","BK1583","LU2488822045.USD","BK0239","IBBQ","09995","LU2148510915.USD","159992","LU1969619763.USD","06978","BK1161","520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652251206","title":"港股通创新药突遭重挫,520880放量溢价!A股制药板块韧性凸显,场内唯一药ETF周线逆市收红","url":"https://stock-news.laohu8.com/highlight/detail?id=2652251206","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652251206?lang=zh_cn&edition=full","pubTime":"2026-07-19 20:19","pubTimestamp":1784463540,"startTime":"0","endTime":"0","summary":"7月17日,A股港股深度调整,沪指跌3%失守3800点,创指暴跌7.15%,恒指跌1.78%。普跌之际,近期显著回暖的创新药资产亦未能幸免。 港股通创新药波动剧烈,康方生物、荣昌生物等7股跌超10%,100%创新药研发标的——港股通创新药ETF华宝日内振幅达7.83%,收跌6.09%,创上市以来最大单日跌幅。不过场内持续溢价,显示买盘态度积极,或有资金逢跌介入。 A股制药板块连涨6日后突变,7股跌超10%,荣昌生物领跌15.51%,权重股科伦药业、海思科跌停。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-07-19/doc-iniikare4940014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","BK4588","BK1574","IBBQ","BK1161","FLHK","MEDX","159982","FDN","399300","01477","BK4585","520880","BK4550","06978","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652440087","title":"创新药遭“错杀”?AH十余股狂泻逾10%!港股通创新药ETF(520880)、场内唯一药ETF同创历史最大单日跌幅","url":"https://stock-news.laohu8.com/highlight/detail?id=2652440087","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652440087?lang=zh_cn&edition=full","pubTime":"2026-07-17 19:15","pubTimestamp":1784286900,"startTime":"0","endTime":"0","summary":"7月17日,A股港股深度调整,沪指跌3%失守3800点,创指暴跌7.15%,恒指跌1.78%。普跌之际,近期显著回暖的创新药资产亦未能幸免。 港股通创新药波动剧烈,康方生物、荣昌生物等7股跌超10%,100%创新药研发标的——港股通创新药ETF华宝日内振幅达7.83%,收跌6.09%,创上市以来最大单日跌幅。 本周来看,港股通创新药ETF华宝场内累跌3.79%,成交43.65亿元续创历史次高,继续放量反映热度仍高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-07-17/doc-iniickaw4155351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","FLHK","IBBQ","BK4585","FDN","BK4550","159316","BK1161","BK1574","MEDX","BK4588","520880","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651491636","title":"【ETF动向】7月15日港股通创新药ETF华宝基金涨3.81%,份额减少1.1亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2651491636","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651491636?lang=zh_cn&edition=full","pubTime":"2026-07-16 06:32","pubTimestamp":1784154736,"startTime":"0","endTime":"0","summary":"证券之星消息,7月15日,港股通创新药ETF华宝基金(520880)涨3.81%,成交额11.55亿元。当日份额减少了1.1亿份,最新份额为51.98亿份,近20个交易日份额减少9.02亿份。当日资金净流入4601.24万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为24.15亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-4.05%,近一个月超额回报为0.45%,管理人为华宝基金公司,基金经理为丰晨成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600005560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651268741","title":"创新药再度活跃!场内唯一药ETF(562050)逆市涨超1%四连升!港股通创新药ETF华宝(520880)盘中翻红!","url":"https://stock-news.laohu8.com/highlight/detail?id=2651268741","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651268741?lang=zh_cn&edition=full","pubTime":"2026-07-14 10:51","pubTimestamp":1783997460,"startTime":"0","endTime":"0","summary":" 7月14日早盘,AH创新药再度活跃,重仓A股创新药的药ETF华宝、满仓港药的港股通创新药ETF华宝双双逆市飘红。 A股制药板块震荡走高,创新药概念股科伦药业大涨超6%,百济神州、新和成涨超2%,场内唯一跟踪制药指数的药ETF华宝逆市涨超1%四连升。 值得一提的是,昨日药ETF华宝全天成交5627万元续创历史天量! 港股通创新药早盘探底回升,100%创新药研发标的——港股通创新药ETF华宝盘中翻红,振幅近3%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2026-07-14/doc-inihtvtz7319923.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["520880","BK1161","06978","BK4550","BK4585","562050","FDN","BK1574","IBBQ","159992","BK4588","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650701130","title":"【ETF动向】7月10日港股通创新药ETF华宝基金涨3.46%,份额减少1.1亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2650701130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650701130?lang=zh_cn&edition=full","pubTime":"2026-07-11 06:32","pubTimestamp":1783722730,"startTime":"0","endTime":"0","summary":"证券之星消息,7月10日,港股通创新药ETF华宝基金(520880)涨3.46%,成交额9.59亿元。当日份额减少了1.1亿份,最新份额为52.94亿份,近20个交易日份额减少9.24亿份。当日资金净流入2659.07万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为23.61亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-3.77%,近一个月超额回报为0.53%,管理人为华宝基金公司,基金经理为丰晨成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071100004453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650091029","title":"19亿美元!国产创新药叒爆BD大单!港股通创新药应声反弹,520880摸高2.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650091029","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650091029?lang=zh_cn&edition=full","pubTime":"2026-07-09 10:38","pubTimestamp":1783564680,"startTime":"0","endTime":"0","summary":"创新药BD出海再添大单!中国生物制药最新公告,将旗下PDE3/4抑制剂TQC3721授予阿斯利康中国以外地区独家许可,首付款2亿美元,开发、监管及销售里程碑合计最高可达19亿美元,另享最高双位数百分比的分级特许权使用费。 二级市场火速响应,7月9日早盘,中国生物制药高开高走,一度涨超6%,所在港股通创新药板块大面积回暖,100%布局创新药研发龙头的港股通创新药ETF华宝摸高2.54%,截至发稿涨0.92%,成交超4亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-07-09/doc-inihenaz1477348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["520880","FLHK","BK1161","06978","BD","BK1574","IBBQ","159992","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649674002","title":"【ETF动向】7月6日港股通创新药ETF华宝基金涨2.73%,份额减少1.1亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2649674002","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649674002?lang=zh_cn&edition=full","pubTime":"2026-07-07 06:31","pubTimestamp":1783377108,"startTime":"0","endTime":"0","summary":"证券之星消息,7月6日,港股通创新药ETF华宝基金(520880)涨2.73%,成交额12.36亿元。当日份额减少了1.1亿份,最新份额为54.02亿份,近20个交易日份额减少8.38亿份。当日资金净流入1815.11万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为24.65亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-4.16%,近一个月超额回报为0.16%,管理人为华宝基金公司,基金经理为丰晨成。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700004420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649629593","title":"爆量突破!超级赛道回归?港股通创新药ETF华宝(520880)冲高6.36%,场内唯一药ETF逆市四连阳!","url":"https://stock-news.laohu8.com/highlight/detail?id=2649629593","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649629593?lang=zh_cn&edition=full","pubTime":"2026-07-06 19:48","pubTimestamp":1783338480,"startTime":"0","endTime":"0","summary":"7月6日,创新药继续上攻,闪“药”全场!港股通创新药再担反弹急先锋,100%创新药研发标的——港股通创新药ETF华宝早盘上探6.36%冲破60日均线,尽管午后随市回落,场内价格仍收涨2.73%走出四连阳。 行情火热,板块人气急速飙升,520880场内交投异常火热,全天成交额达12.36亿元,创下2025年8月以来新高! 药ETF华宝创新药含量超75%,上周场内累涨14.78%,同样刷新单周涨幅最高纪录。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-07-06/doc-inifwmvs1897040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["520880","FDN","BK4585","BK4588","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648639317","title":"【ETF动向】7月2日港股通创新药ETF华宝基金涨3.7%,份额减少1.1亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2648639317","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648639317?lang=zh_cn&edition=full","pubTime":"2026-07-03 06:31","pubTimestamp":1783031517,"startTime":"0","endTime":"0","summary":"证券之星消息,7月2日,港股通创新药ETF华宝基金(520880)涨3.7%,成交额9.05亿元。当日份额减少了1.1亿份,最新份额为56.2亿份,近20个交易日份额减少6.4亿份。当日资金净流入9498.06万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为23.78亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-3.83%,近一个月超额回报为0.14%,管理人为华宝基金公司,基金经理为丰晨成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300006322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647585708","title":"顿悟了!玻璃不仅能造芯片,还能装药...","url":"https://stock-news.laohu8.com/highlight/detail?id=2647585708","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647585708?lang=zh_cn&edition=full","pubTime":"2026-06-30 09:29","pubTimestamp":1782782940,"startTime":"0","endTime":"0","summary":" 大家好啊,新的一周,心惊动魄,医药全天最靓的崽;科技里面开始分化,半导体继续强劲。 看下周一的涨幅榜,被医药和半导体刷屏了! 复盘下行情,从2025年9月高点至今,创新药指数跌幅超过26%,中证医药指数一度探至2014年以来新低。 以上就构成了尖锐的矛盾,A股医药的基本面在改善,股价却在探底。 医药魔方预测2026年全年中国创新药BD交易总额有望突破1500亿美元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-06-30/doc-inifcvua1738474.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["562050","520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647300164","title":"【ETF动向】6月29日港股通创新药ETF华宝基金涨7.94%,份额减少1.1亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2647300164","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647300164?lang=zh_cn&edition=full","pubTime":"2026-06-30 06:31","pubTimestamp":1782772316,"startTime":"0","endTime":"0","summary":"证券之星消息,6月29日,港股通创新药ETF华宝基金(520880)涨7.94%,成交额8.61亿元。当日份额减少了1.1亿份,最新份额为58.4亿份,近20个交易日份额减少1.14亿份。当日资金净流入1.15亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为23.78亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-3.67%,近一个月超额回报为0.16%,管理人为华宝基金公司,基金经理为丰晨成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000005717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646823750","title":"创新药再陷调整!场内唯一药ETF止步四连涨,港股通创新药大面积飘绿,520880跌逾2.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646823750","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646823750?lang=zh_cn&edition=full","pubTime":"2026-06-25 10:57","pubTimestamp":1782356220,"startTime":"0","endTime":"0","summary":"6月25日,AH创新药再陷调整,重仓A股创新药的药ETF华宝、满仓港药的港股通创新药ETF华宝盘中一度双双跌超2%。 A股制药板块普跌,核心权重股恒瑞医药跌1.5%,新和成、复星医药跌3%,场内唯一表征制药板块的药ETF华宝止步四连阳。 港股通创新药低开低走,100%创新药研发标的——港股通创新药ETF华宝尽吐昨日涨幅,权重龙头尽墨,信达生物跌超2%,石药集团、康方生物、中国生物制药齐跌逾3%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-06-25/doc-inieqskw1106960.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["FDN","BK1161","BK4588","BK4550","VXUS","BK4585","159992","BK1574","06978","520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646884458","title":"【ETF动向】6月24日港股通创新药ETF华宝基金涨2.36%,份额减少1亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2646884458","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646884458?lang=zh_cn&edition=full","pubTime":"2026-06-25 06:32","pubTimestamp":1782340337,"startTime":"0","endTime":"0","summary":"证券之星消息,6月24日,港股通创新药ETF华宝基金(520880)涨2.36%,成交额6.69亿元。当日份额减少了1亿份,最新份额为59.8亿份,近20个交易日份额增加400万份。当日资金净流出1288.76万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为23.34亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-3.42%,近一个月超额回报为0.17%,管理人为华宝基金公司,基金经理为丰晨成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500004725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645897118","title":"CXO成反弹急先锋?高CXO含量港股通医疗ETF华宝(159137)盘中劲涨5.44%!创新药同步回血,520880上探4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645897118","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645897118?lang=zh_cn&edition=full","pubTime":"2026-06-24 19:26","pubTimestamp":1782300360,"startTime":"0","endTime":"0","summary":"6月24日,港股通医药久违大涨,创新药产业链强劲反攻!CXO一马当先:凯莱英狂飙13.12%,金斯瑞生物科技涨11.5%紧随其后,药明系权重龙头药明合联、药明康德、药明生物分别收涨8.88%、8.33%、4.17%。 港股通医疗ETF华宝超四成仓位布局CXO龙头,盘中最高涨幅达5.44%尽显高弹性,收涨4.35%连收5日及10日均线,成交6531万元创近4个月新高! 中报季临近,多家机构重点提示CXO板块投资机会,其中华福证券明确表示,重视CXO全年战略配置价值,并给出三点依据:","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-06-24/doc-iniepeiq1495055.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159137","BK4585","159992","BK1161","BK4588","VXUS","06978","520880","CXO","512170","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643321518","title":"【ETF动向】6月12日港股通创新药ETF华宝基金涨3.66%,份额减少9000万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2643321518","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643321518?lang=zh_cn&edition=full","pubTime":"2026-06-13 06:31","pubTimestamp":1781303504,"startTime":"0","endTime":"0","summary":"证券之星消息,6月12日,港股通创新药ETF华宝基金(520880)涨3.66%,成交额5.28亿元。当日份额减少了9000万份,最新份额为61.28亿份,近20个交易日份额增加5.58亿份。当日资金净流入3495.28万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为24.46亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-3.75%,近一个月超额回报为-0.01%,管理人为华宝基金公司,基金经理为丰晨成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061300004713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788562994225,"stockEarnings":[{"period":"1week","weight":-0.0085},{"period":"1month","weight":0.0661},{"period":"3month","weight":0.1818},{"period":"6month","weight":-0.041},{"period":"1year","weight":-0.2699},{"period":"ytd","weight":-0.0602}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":0.0133},{"period":"3month","weight":-0.0242},{"period":"6month","weight":-0.0471},{"period":"1year","weight":0.0436},{"period":"ytd","weight":-0.0098}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"港股通创新药ETF华宝(520880)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供港股通创新药ETF华宝(520880)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"港股通创新药ETF华宝,520880,港股通创新药ETF华宝股票,港股通创新药ETF华宝股票老虎,港股通创新药ETF华宝股票老虎国际,港股通创新药ETF华宝行情,港股通创新药ETF华宝股票行情,港股通创新药ETF华宝股价,港股通创新药ETF华宝股市,港股通创新药ETF华宝股票价格,港股通创新药ETF华宝股票交易,港股通创新药ETF华宝股票购买,港股通创新药ETF华宝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"港股通创新药ETF华宝(520880)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供港股通创新药ETF华宝(520880)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}